HCV phylogenetic Signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland China.

Lai Wei,Masao Omata,Young-Suk Lim,Qing Xie,Jin Lin Hou,Jidong Jia,Charlotte Hedskog,Ross Martin,Brian Doehle,Jenny Yang,Shampa De-Oertel,Benedetta Massetto,Kathryn Kersey,Diana M Brainard,Evguenia Svarovskaia,Hongmei Mo,Kwang-Hyub Han,Masashi Mizokami,Zhongping Duan
DOI: https://doi.org/10.1016/j.antiviral.2018.08.001
IF: 7.6
2018-01-01
Antiviral Research
Abstract:•Prevalence of HCV subtypes and resistance associated substitutions (RAS) in China were investigated.•HCV subtypes and RAS in China were compared to other Asian counties, North America and Europe.•Differences in the prevalence of GT2 and GT3 subtypes and NS5A RAS were observed between Asian and Western countries.
What problem does this paper attempt to address?